Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations

BACKGROUND: Gastric cancer (GC) is a highly heterogeneous disease with many different histological and molecular subtypes. Due to their reduced systemic adverse effects, nanoformulation agents have attracted increasing attention for use in the treatment of GC patients in the clinic. To improve thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jiale, Wang, Shuang, Chai, Ningli, Yue, Hua, Ye, Peng, Guo, Peilin, Li, Feng, Wei, Bo, Ma, Guanghui, Wei, Wei, Linghu, Enqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118843/
https://www.ncbi.nlm.nih.gov/pubmed/35585597
http://dx.doi.org/10.1186/s12951-022-01431-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118843/
https://www.ncbi.nlm.nih.gov/pubmed/35585597
http://dx.doi.org/10.1186/s12951-022-01431-8

Ejemplares similares